Celcuity Inc

Celcuity Inc

CELC

Get informed when a big investor buys or sells

+ Follow
Market Cap$6.48B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Celcuity IncCelcuity Inc-37.5--360%-3.7
$157.00

Target Price by Analysts

69.8% upsideCelcuity Target Price DetailsTarget Price
$-0.56

Current Fair Value

100.6% downside

Overvalued by 100.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.48 Billion
Enterprise Value$6.53 Billion
Dividend Yield$- (-)
Earnings per Share$-3.78
Beta0.09
Outstanding Shares54,462,826

Return

Return on Equity-360.37%ROE
Return on Assets-47.03%
Return on Invested Capital-44.62%

Valuation & Multiples

P/E Ratio-37.52P/E Ratio
PEG-87.61PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue42405.53
Enterprise Value to EBIT-38.82
Enterprise Value to Net Income-34
Total Debt to Enterprise0.03
Debt to Equity3.65Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 14, 2026
EPS Estimate
$-1.07
Average shareholder expectation
Revenue Estimate
$2.94 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 6, 2026
EPS Estimate
$-1.12
Average shareholder expectation
Revenue Estimate
$4.42 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.2810 16.44%
Total Calls1,845,945 59.88%
Total Puts518,800 285.15%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %93.33% 14.03%
Total Invested$5.58B 16.03%
Investors Holding292 41.00%

ESG Score

No data

About Celcuity Inc

Relevant Senate Committees

Joint Committee on Taxation

This committee provides crucial 'revenue estimates' for all tax legislation, directly influencing corporate tax structures and capital investment credits. Its technical expertise and scoring function have a direct and significant impact on the financial burden and strategy for all companies, including Celcuity.

Finance

This powerful committee controls taxation, trade, and entitlement spending, including Medicare. Decisions on Medicare pricing and reimbursement rates for diagnostic tests are a primary driver of revenue and profitability for medical laboratories like Celcuity.

Appropriations

This committee allocates discretionary federal spending. Its subcommittees determine precise funding for scientific research, public health initiatives, and federal healthcare programs, directly affecting potential grants, contracts, and revenue streams for medical laboratories.

Health, Education, Labor, and Pensions

This committee directly regulates the FDA and NIH. The FDA's oversight of diagnostic tests (including Lab Developed Tests and IVDs) is paramount to medical laboratories, and NIH funding is a major driver of medical research in which labs participate.

Judiciary

This committee oversees antitrust laws and intellectual property. Intellectual property (patents for diagnostic tests and methodologies) is critical for medical laboratories, and antitrust oversight could impact potential mergers and acquisitions in the industry.

Veterans' Affairs

This committee oversees the Department of Veterans Affairs. Funding decisions and policies directly impact government healthcare contractors, meaning Celcuity could be significantly affected if it provides diagnostic services or research to the VA.